Ascent Innovative Medicines Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 5.00 Cr
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 27.37%
- Profit Growth 55.08%
- Ebitda 63.97%
- Net Worth -20.68%
- Total Assets -15.47%
About Ascent Innovative Medicines
Ascent Innovative Medicines Private Limited (AIMPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 February 2016 (Nine years and one month 18 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Subodh Gupta and Suresh Deora serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74900MH2016PTC273442
- Company No.
273442
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Ascent Innovative Medicines Private Limited
Explore comprehensive data for Ascent Innovative Medicines Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Ascent Innovative Medicines?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subodh Gupta  | Managing Director | 24-Feb-2016 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suresh Deora | Director | 24-Feb-2016 | Current |
Financial Performance of Ascent Innovative Medicines.
Ascent Innovative Medicines Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 27.37% increase. The company also saw a substantial improvement in profitability, with a 55.08% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ascent Innovative Medicines?
In 2021, Ascent Innovative Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
S.A.Pharmachem Private LimitedSuresh Deora is a mutual person
All India Manufacturers OrganizationSuresh Deora is a mutual person
Celligo Natural Fibres Private LimitedSubodh Gupta is a mutual person
Intellimation.Ai Software Private LimitedSubodh Gupta is a mutual person
Terrasoul Polymers Private LimitedSubodh Gupta is a mutual person
- Pds Healthcare Llp
Suresh Deora is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ascent Innovative Medicines?
Ascent Innovative Medicines has a workforce of 8 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ascent Innovative Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ascent Innovative Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Ascent Innovative Medicines
Recent activity within the organization
- Annual General Meeting
Ascent Innovative Medicines Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Ascent Innovative Medicines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
- Director Appointment
Subodh Gupta was appointed as a Managing Director was appointed as a Managing Director on 24 Feb 2016 & has been associated with this company since 9 years 1 month .
- Director Appointment
Suresh Mahabirprasad Deora was appointed as a Director was appointed as a Director on 24 Feb 2016 & has been associated with this company since 9 years 1 month .
- Company Incorporation
Ascent Innovative Medicines Private Limited was registered on 24 Feb 2016 with Roc Mumbai & aged 9 years 1 month as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Ascent Innovative Medicines Private Limited?
Ascent Innovative Medicines Private Limited was incorporated on 24 Feb 2016.
What is authorized share capital and paid-up capital of Ascent Innovative Medicines Private Limited?
The authorized share capital of Ascent Innovative Medicines Private Limited is ₹ 5.00 Cr and paid-up capital is ₹ 5.00 Cr.
Who are the current board members & directors of Ascent Innovative Medicines Private Limited?
Currently 2 directors are associated with Ascent Innovative Medicines Private Limited.
- Subodh Gupta
- Suresh Mahabirprasad Deora
What is the registered address of Ascent Innovative Medicines Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Ascent Innovative Medicines Private Limited is 54-A Elite Auto House Andheri Kurla Road, East India, Mumbai, Maharashtra, 400093.
What is the corporate identification number (CIN) and company number of Ascent Innovative Medicines Private Limited?
The corporate identification number (CIN) of Ascent Innovative Medicines Private Limited is U74900MH2016PTC273442 and the company number is 273442 as per Ministry of Corporate Affairs (MCA).
What is the official website of Ascent Innovative Medicines Private Limited?
The Official website of Ascent Innovative Medicines Private Limited is https://www.ascentinnovative.com
What has been the recent revenue trend for Ascent Innovative Medicines Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Ascent Innovative Medicines Private Limited has risen by 27.37%.
How many employees does Ascent Innovative Medicines Private Limited currently have?
As Per 2022 financial reports, 8 employees are currently employed by Ascent Innovative Medicines Private Limited.
What change has been observed in the net worth of Ascent Innovative Medicines Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Ascent Innovative Medicines Private Limited has experienced an downturn of -20.68%.
When was the last Balance Sheet of Ascent Innovative Medicines Private Limited filed with the ROC?
The most recent Balance Sheet for Ascent Innovative Medicines Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
HM
Hemadri MittadoddiDirectorSR
Sunilendu RoyDirector
Similar Companies Based on Pharma Contract R&D
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India